Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Prenatal exposure to opioid maintenance treatment and neonatal outcomes: Nationwide registry studies from the Czech Republic and Norway.

Handal M, Nechanská B, Skurtveit S, Lund IO, Gabrhelík R, Engeland A, Mravčík V.

Pharmacol Res Perspect. 2019 Aug 14;7(5):e00501. doi: 10.1002/prp2.501. eCollection 2019 Oct.

2.

Time Intervals From Onset of Clinical Manifestations to Treatment in Patients With Cancer at Hospital General San Felipe, Tegucigalpa, Honduras.

Sánchez JA, Handal MG, Vílchez Rodriguez JF, Mejía SI, Pagoaga AP.

J Glob Oncol. 2019 Jun;5:1-7. doi: 10.1200/JGO.19.00107.

3.

Association of Maternal Use of Benzodiazepines and Z-Hypnotics During Pregnancy With Motor and Communication Skills and Attention-Deficit/Hyperactivity Disorder Symptoms in Preschoolers.

Lupattelli A, Chambers CD, Bandoli G, Handal M, Skurtveit S, Nordeng H.

JAMA Netw Open. 2019 Apr 5;2(4):e191435. doi: 10.1001/jamanetworkopen.2019.1435. Erratum in: JAMA Netw Open. 2019 May 3;2(5):e194291.

4.

Hospitalization of children after prenatal exposure to opioid maintenance therapy during pregnancy: a national registry study from the Czech Republic.

Skurtveit S, Nechanská B, Handal M, Mahic M, Mravčík V, Gabrhelík R.

Addiction. 2019 Jul;114(7):1225-1235. doi: 10.1111/add.14576. Epub 2019 Mar 12.

PMID:
30725515
5.

Association of Constellations of Parental Risk With Children's Subsequent Anxiety and Depression: Findings From a HUNT Survey and Health Registry Study.

Lund IO, Skurtveit S, Handal M, Bukten A, Ask Torvik F, Ystrøm E, Burdzovic Andreas J.

JAMA Pediatr. 2019 Mar 1;173(3):251-259. doi: 10.1001/jamapediatrics.2018.4360.

PMID:
30615089
6.

A complete national cohort study of prescriptions of analgesics and benzodiazepines to cancer survivors in Norway 10 years after diagnosis.

Fredheim OM, Skurtveit S, Handal M, Hjellvik V.

Pain. 2019 Apr;160(4):852-859. doi: 10.1097/j.pain.0000000000001459.

PMID:
30531310
7.

Can measurements of heroin metabolites in post-mortem matrices other than peripheral blood indicate if death was rapid or delayed?

Thaulow CH, Øiestad ÅML, Rogde S, Andersen JM, Høiseth G, Handal M, Mørland J, Vindenes V.

Forensic Sci Int. 2018 Sep;290:121-128. doi: 10.1016/j.forsciint.2018.06.041. Epub 2018 Jul 5.

PMID:
30015276
8.

Increase in diagnosis of depressive disorders contributes to the increase in antidepressant use in adolescents.

Skurtveit S, Bramness JG, Hjellvik V, Hartz I, Nesvåg R, Hauge LJ, Handal M.

Acta Psychiatr Scand. 2018 May;137(5):413-421. doi: 10.1111/acps.12877. Epub 2018 Apr 5.

PMID:
29623693
9.

Effect of Time-Dependent Selective Serotonin Reuptake Inhibitor Antidepressants During Pregnancy on Behavioral, Emotional, and Social Development in Preschool-Aged Children.

Lupattelli A, Wood M, Ystrom E, Skurtveit S, Handal M, Nordeng H.

J Am Acad Child Adolesc Psychiatry. 2018 Mar;57(3):200-208. doi: 10.1016/j.jaac.2017.12.010. Epub 2017 Dec 28.

10.

Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway.

Nechanská B, Mravčík V, Skurtveit S, Lund IO, Gabrhelík R, Engeland A, Handal M.

Addiction. 2018 Jul;113(7):1286-1294. doi: 10.1111/add.14192. Epub 2018 Mar 24.

11.

Metabolites of Heroin in Several Different Post-mortem Matrices.

Thaulow CH, Øiestad ÅML, Rogde S, Karinen R, Brochmann GW, Andersen JM, Høiseth G, Handal M, Mørland J, Arnestad M, Øiestad EL, Strand DH, Vindenes V.

J Anal Toxicol. 2018 Jun 1;42(5):311-320. doi: 10.1093/jat/bky002.

PMID:
29409037
12.

The incidence, psychiatric co-morbidity and pharmacological treatment of severe mental disorders in children and adolescents.

Nesvåg R, Bramness JG, Handal M, Hartz I, Hjellvik V, Skurtveit S.

Eur Psychiatry. 2018 Mar;49:16-22. doi: 10.1016/j.eurpsy.2017.12.009. Epub 2018 Feb 3.

PMID:
29366845
13.

Hypnotics use in children 0-18 months: moderate agreement between mother-reported survey data and prescription registry data.

Holdø I, Bramness JG, Handal M, Torgersen L, Reichborn-Kjennerud T, Ystrøm E, Nordeng H, Skurtveit S.

J Pharm Policy Pract. 2017 Sep 8;10:28. doi: 10.1186/s40545-017-0117-7. eCollection 2017.

14.

Association of prenatal exposure to benzodiazepines and child internalizing problems: A sibling-controlled cohort study.

Brandlistuen RE, Ystrom E, Hernandez-Diaz S, Skurtveit S, Selmer R, Handal M, Nordeng H.

PLoS One. 2017 Jul 26;12(7):e0181042. doi: 10.1371/journal.pone.0181042. eCollection 2017.

15.

Language competence and communication skills in 3-year-old children after prenatal exposure to analgesic opioids.

Skovlund E, Handal M, Selmer R, Brandlistuen RE, Skurtveit S.

Pharmacoepidemiol Drug Saf. 2017 Jun;26(6):625-634. doi: 10.1002/pds.4170. Epub 2017 Feb 7.

PMID:
28168770
16.

Motor development in children prenatally exposed to selective serotonin reuptake inhibitors: a large population-based pregnancy cohort study.

Handal M, Skurtveit S, Furu K, Hernandez-Diaz S, Skovlund E, Nystad W, Selmer R.

BJOG. 2016 Nov;123(12):1908-1917. doi: 10.1111/1471-0528.13582. Epub 2015 Sep 15.

17.

A Unique Opportunity to Study Short and Long Term Consequences in Children Prenatally Exposed to Illicit Drugs and Opioid Maintenance Treatment Using Czech and Scandinavian Registers.

Gabrhelík R, Nechanská B, Mravčík V, Skurtveit S, Lund IO, Handal M.

Cent Eur J Public Health. 2016 Sep;24(3):248-251. doi: 10.21101/cejph.a4474.

18.

Long-term Use of Z-Hypnotics and Co-medication with Benzodiazepines and Opioids.

Sakshaug S, Handal M, Hjellvik V, Berg C, Ripel Å, Gustavsen I, Mørland J, Skurtveit S.

Basic Clin Pharmacol Toxicol. 2017 Mar;120(3):292-298. doi: 10.1111/bcpt.12684. Epub 2016 Dec 6.

19.

Antidepressant drug use among adolescents during 2004-2013: a population-based register linkage study.

Hartz I, Skurtveit S, Hjellvik V, Furu K, Nesvåg R, Handal M.

Acta Psychiatr Scand. 2016 Nov;134(5):420-429. doi: 10.1111/acps.12633. Epub 2016 Aug 29.

20.

Mental disorder diagnoses among children and adolescents who use antipsychotic drugs.

Nesvåg R, Hartz I, Bramness JG, Hjellvik V, Handal M, Skurtveit S.

Eur Neuropsychopharmacol. 2016 Sep;26(9):1412-1418. doi: 10.1016/j.euroneuro.2016.07.001. Epub 2016 Jul 21.

PMID:
27452144
21.

Prenatal Exposure to Folic Acid and Antidepressants and Language Development: A Population-Based Cohort Study.

Handal M, Skurtveit S, Roth C, Hernandez-Diaz S, Selmer R.

J Clin Psychopharmacol. 2016 Aug;36(4):333-9. doi: 10.1097/JCP.0000000000000519.

PMID:
27285658
22.

Benzodiazepine prescription for patients in treatment for drug use disorders: a nationwide cohort study in Denmark, 2000-2010.

Tjagvad C, Clausen T, Handal M, Skurtveit S.

BMC Psychiatry. 2016 May 27;16:168. doi: 10.1186/s12888-016-0881-y.

23.

Cohort Profile Update: The Norwegian Mother and Child Cohort Study (MoBa).

Magnus P, Birke C, Vejrup K, Haugan A, Alsaker E, Daltveit AK, Handal M, Haugen M, Høiseth G, Knudsen GP, Paltiel L, Schreuder P, Tambs K, Vold L, Stoltenberg C.

Int J Epidemiol. 2016 Apr;45(2):382-8. doi: 10.1093/ije/dyw029. Epub 2016 Apr 10.

PMID:
27063603
24.

Psychotropic drug use among 0-17 year olds during 2004-2014: a nationwide prescription database study.

Hartz I, Skurtveit S, Steffenak AK, Karlstad Ø, Handal M.

BMC Psychiatry. 2016 Jan 29;16:12. doi: 10.1186/s12888-016-0716-x.

25.

A Cohort Study on Long-Term Adverse Effects of Parental Drinking: Background and Study Design.

Lund IO, Bukten A, Storvoll EE, Moan IS, Skurtveit S, Handal M, Nordfjaern T, Brunborg GS, Rossow I.

Subst Abuse. 2015 Dec 15;9(Suppl 2):77-83. doi: 10.4137/SaRt.S23329. eCollection 2015.

26.

Paediatric Off-Label Use of Melatonin--A Register Linkage Study between the Norwegian Prescription Database and Patient Register.

Hartz I, Handal M, Tverdal A, Skurtveit S.

Basic Clin Pharmacol Toxicol. 2015 Oct;117(4):267-73. doi: 10.1111/bcpt.12411. Epub 2015 May 9.

27.

Commentary on Raitasalo et al. (2015): the great potential in nation-wide registers to study prescription drug use and abuse.

Lund IO, Skurtveit S, Handal M.

Addiction. 2015 Apr;110(4):644-5. doi: 10.1111/add.12856. No abstract available.

PMID:
25771690
28.

Reduced prescribing of benzodiazepines in Denmark and Norway.

Berg C, Skurtveit S, Sakshaug S, Hjellvik V, Handal M.

Basic Clin Pharmacol Toxicol. 2015 Jun;116(6):457-8. doi: 10.1111/bcpt.12377. Epub 2015 Feb 17. No abstract available.

29.

Prenatal exposure to anxiolytics and hypnotics and language competence at 3 years of age.

Odsbu I, Skurtveit S, Selmer R, Roth C, Hernandez-Diaz S, Handal M.

Eur J Clin Pharmacol. 2015 Mar;71(3):283-91. doi: 10.1007/s00228-014-1797-4. Epub 2014 Dec 30.

PMID:
25547568
30.

Dispensing of benzodiazepines and benzodiazepine-related drugs to pregnant women: a population-based cohort study.

Riska BS, Skurtveit S, Furu K, Engeland A, Handal M.

Eur J Clin Pharmacol. 2014 Nov;70(11):1367-74. doi: 10.1007/s00228-014-1744-4. Epub 2014 Sep 11.

PMID:
25204310
31.

Pharmacokinetic interactions between ethanol and heroin: a study on post-mortem cases.

Thaulow CH, Høiseth G, Andersen JM, Handal M, Mørland J.

Forensic Sci Int. 2014 Sep;242:127-134. doi: 10.1016/j.forsciint.2014.06.032. Epub 2014 Jul 6.

PMID:
25050840
32.

Prenatal exposure to antidepressants and language competence at age three: results from a large population-based pregnancy cohort in Norway.

Skurtveit S, Selmer R, Roth C, Hernandez-Diaz S, Handal M.

BJOG. 2014 Dec;121(13):1621-31. doi: 10.1111/1471-0528.12821. Epub 2014 Apr 14.

33.

Association between prescribing hypnotics for parents and children in Norway.

Holdø I, Handal M, Skurtveit S, Bramness JG.

Arch Dis Child. 2013 Sep;98(9):732-6. doi: 10.1136/archdischild-2013-303646. Epub 2013 Jul 11.

PMID:
23845695
34.

Drug exposure: inclusion of dispensed drugs before pregnancy may lead to underestimation of risk associations.

Skurtveit S, Selmer R, Tverdal A, Furu K, Nystad W, Handal M.

J Clin Epidemiol. 2013 Sep;66(9):964-72. doi: 10.1016/j.jclinepi.2013.02.011. Epub 2013 Jun 22.

PMID:
23800534
35.

Midlife vascular risk factors and their association with dementia deaths: results from a Norwegian prospective study followed up for 35 years.

Strand BH, Langballe EM, Hjellvik V, Handal M, Næss O, Knudsen GP, Refsum H, Tambs K, Nafstad P, Schirmer H, Bergem AL, Selmer R, Engedal K, Magnus P, Bjertness E; GENIDEM-Group.

J Neurol Sci. 2013 Jan 15;324(1-2):124-30. doi: 10.1016/j.jns.2012.10.018. Epub 2012 Nov 10.

PMID:
23146611
36.

Hypnotic drug use among 0-17 year olds during 2004-2011: a nationwide prescription database study.

Hartz I, Furu K, Bratlid T, Handal M, Skurtveit S.

Scand J Public Health. 2012 Dec;40(8):704-11. doi: 10.1177/1403494812464446. Epub 2012 Oct 29.

PMID:
23108475
37.

Prescription drug use among pregnant women in opioid Maintenance Treatment.

Lund IO, Skurtveit S, Engeland A, Furu K, Ravndal E, Handal M.

Addiction. 2013 Feb;108(2):367-76. doi: 10.1111/j.1360-0443.2012.04049.x. Epub 2012 Oct 18.

PMID:
22882166
38.

[Co-medication with benzodiazepines].

Handal M, Skurtveit S, Mørland JG.

Tidsskr Nor Laegeforen. 2012 Mar 6;132(5):526-30. doi: 10.4045/tidsskr.11.0321. Norwegian.

39.

Use of prescribed opioid analgesics and co-medication with benzodiazepines in women before, during, and after pregnancy: a population-based cohort study.

Handal M, Engeland A, Rønning M, Skurtveit S, Furu K.

Eur J Clin Pharmacol. 2011 Sep;67(9):953-60. doi: 10.1007/s00228-011-1030-7. Epub 2011 Apr 12.

PMID:
21484468
40.

To what extent does a cohort of new users of weak opioids develop persistent or probable problematic opioid use?

Skurtveit S, Furu K, Borchgrevink P, Handal M, Fredheim O.

Pain. 2011 Jul;152(7):1555-61. doi: 10.1016/j.pain.2011.02.045. Epub 2011 Mar 29.

PMID:
21450405
41.

The association between smoking and subsequent repeated use of prescribed opioids among adolescents and young adults--a population-based cohort study.

Log T, Hartz I, Handal M, Tverdal A, Furu K, Skurtveit S.

Pharmacoepidemiol Drug Saf. 2011 Jan;20(1):90-8. doi: 10.1002/pds.2066. Epub 2010 Dec 1.

PMID:
21182157
42.

Nicotine dependence predicts repeated use of prescribed opioids. Prospective population-based cohort study.

Skurtveit S, Furu K, Selmer R, Handal M, Tverdal A.

Ann Epidemiol. 2010 Dec;20(12):890-7. doi: 10.1016/j.annepidem.2010.03.010. Epub 2010 Jun 2.

PMID:
20627770
43.

Interactions between morphine and the morphine-glucuronides measured by conditioned place preference and locomotor activity.

Vindenes V, Ripel A, Handal M, Boix F, Mørland J.

Pharmacol Biochem Behav. 2009 Jul;93(1):1-9. doi: 10.1016/j.pbb.2009.03.013. Epub 2009 Apr 5.

PMID:
19351545
44.

Behavioural sensitization in mice induced by morphine-glucuronide metabolites.

Handal M, Ripel A, Skurtveit S, Mørland J.

Pharmacol Biochem Behav. 2008 Oct;90(4):578-85. doi: 10.1016/j.pbb.2008.04.018.

PMID:
18555521
45.

Different time schedules affect conditioned place preference after morphine and morphine-6-glucuronide administration.

Vindenes V, Handal M, Ripel A, Thaulow CH, Vindenes HB, Boix F, Mørland J.

Pharmacol Biochem Behav. 2008 May;89(3):374-83. doi: 10.1016/j.pbb.2008.01.012. Epub 2008 Jan 26.

PMID:
18308383
46.

Morphine-3-glucuronide inhibits morphine induced, but enhances morphine-6-glucuronide induced locomotor activity in mice.

Handal M, Ripel A, Aasmundstad T, Skurtveit S, Mørland J.

Pharmacol Biochem Behav. 2007 Mar;86(3):576-86. Epub 2007 Feb 8.

PMID:
17343905
47.

Conditioned place preference induced by morphine and morphine-6-glucuronide in mice.

Vindenes V, Handal M, Ripel A, Boix F, Mørland J.

Pharmacol Biochem Behav. 2006 Oct;85(2):292-7. Epub 2006 Oct 2.

PMID:
17011617
48.

DNA mutation detection and analysis using miniaturized microfluidic systems.

Handal MI, Ugaz VM.

Expert Rev Mol Diagn. 2006 Jan;6(1):29-38. Review.

PMID:
16359265
49.

Pharmacokinetic differences of morphine and morphine-glucuronides are reflected in locomotor activity.

Handal M, Grung M, Skurtveit S, Ripel A, Mørland J.

Pharmacol Biochem Behav. 2002 Nov;73(4):883-92.

PMID:
12213535
50.

Morphine-6-glucuronide-induced locomotor stimulation in mice: role of opioid receptors.

Grung M, Skurtveit S, Aasmundstad TA, Handal M, Alkana RL, Mørland J.

Pharmacol Toxicol. 1998 Jan;82(1):3-10.

PMID:
9527644

Supplemental Content

Loading ...
Support Center